IonQ to highlight enterprise use cases and global momentum at leading quantum event COLLEGE PARK, Md.–(BUSINESS…
Categoría: Business Wire
Categoría agregada por el Plugin WPeMatico
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints…
Perion Launches “SODA” – Next Generation AI-Powered Supply-Side Technology for Web and DOOH Designed to Increase Revenue for Publishers, and Reduce Waste for Advertisers
Already Adopted by Mediatransports, SODA Enables Publishers to Maximize Revenue through AI-Modeling Optimization NEW YORK &…
Casey Graves Joins ConcertAI as General Manager, Clinical Solutions
CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI, a leading provider of multi-modal data and agentic AI solutions for life sciences…
Upbound Group Announces Appointment of Chief Growth Officer
Newly created role will work to bring data-driven, targeted offerings to market for our customers and…
Virtus Investment Partners Reports Preliminary August 31, 2025 Assets Under Management
HARTFORD, Conn.–(BUSINESS WIRE)–Virtus Investment Partners, Inc. (NYSE: VRTS) today reported preliminary assets under management (AUM) of…
KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results
-EKTERLY® now approved in the US and UK; first and only oral on-demand therapy for acute…
Amy B. Mansue Elected to the Board of Directors of New Jersey Resources
WALL, N.J.–(BUSINESS WIRE)–The Board of Directors of New Jersey Resources (NYSE: NJR) announced the unanimous election…
Chaos Announces CEO Transition: Iveta Cabajova promoted to CEO, Stephan Sieber to become Executive Chairman
KARLSRUHE, Germany–(BUSINESS WIRE)–Chaos, a leading provider of visual design software for the architectural, engineering and construction…
CAPR INVESTOR ALERT: Kirby McInerney LLP Notifies Capricor Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK–(BUSINESS WIRE)–Kirby McInerney LLP reminds Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) investors…